As a general comment to the OP, economics is
hard to grasp intuitively. As well, economics under a 'gold standard' system will be
slightly different from economics under a 'fiat money' system. There will be an underlying truth, but the total behaviour is not perfectly comparable. It's like how aeronautics on Mars and on Earth will be different. An Aerospace engineer who only understand Terran planes - no matter how well - cannot efficiently design something for Mars. It's the same with economics under a gold standard: the 'most efficient' or even 'best' policies under a gold standard
will be different than ones under a fiat.
It is true that inflation benefits debtors
You've said this before. It's not true. Only unexpected inflation benefits debtors, and that's only true for the subset whose wages jump before prices jump. Expected inflation hurts debtors and also reduces net investment as it rises. (And expected inflation that doesn't actualize
really really hurts debtors)
edit:
One of the reason we have so many world-class medical research institutions is because we allow them to be private entities and receive private donations to do research for companies.
This is something near-and-dear to my heart. You want all three (charity, government, and private) funding. Each have their specialty and they very much provide massive boosts to the aggregate. In my opinion, if you have loved ones and you're not donating to Alzheimer's research, you're not appreciating the maths on scientific research. These donations generate compounding real returns at rates people just cannot understand using Wall Street financial spreadsheets.
There's no doubt private companies do fundamentally research: but there's only one type they
really do. Stuff that can be commercialized. Sure, there's a trickle of funding into laying down Open Access discoveries, but it's not very much. This research is fundamentally important, but there are hosts and hosts and hosts of discoveries they will never, ever look at.
One of the most-necessary cancer trials (showing that beta-carotene doesn't help prevent lung cancer) had
zero financial incentive at the private levels to be released: cigarette companies wouldn't have released the data; supplement makers wouldn't have released the data. It was funded by charities and by governments.
In general: government provides foundational research. Companies and Charities
constantly peruse these data looking for new insights and mechanisms to be exploited. Charities will then fund pilot projects on anything that
might work based on the cost-effectiveness of getting the data, and we have incentive to publish negative results (though less incentive than nearly everyone would want) and to publish replications (and, with less incentive than optimal). Companies will peruse the publicly released data, and sometimes rush to a discovery or look for discoveries that can be patented. This sometimes helps, and sometimes helps. Occasionally there will be a discovery that's
easily on the known horizon. If it gets done by a charity
first, it's open access. If it's done by a company first, it's patented.